CG Oncology, Inc. (CGON) stock
CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$78.94−5.84 (-6.89%)
Close on Nov 17, 2026Market cap $7.00BP/E –Yield –
CG Oncology total assets
Total assets on the balance sheet at the end of each period.
CG Oncology's total assets was $1.05B at Sep 30, 2026. For fiscal 2025 it was $791.59M, up 4.9% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $791.59M | +4.9% |
| FY2024 | Dec 31, 2024 | $754.80M | +278.7% |
| FY2023 | Dec 31, 2023 | $199.30M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.05B | +43.4% |
| Q2 FY2026 | Jun 30, 2026 | $1.09B | +54.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.14B | +55.9% |
| Q4 FY2025 | Dec 31, 2025 | $791.59M | +4.9% |
| Q3 FY2025 | Sep 30, 2025 | $729.91M | +32.1% |
| Q2 FY2025 | Jun 30, 2025 | $701.45M | +24.3% |
| Q1 FY2025 | Mar 31, 2025 | $728.18M | +25.7% |
| Q4 FY2024 | Dec 31, 2024 | $754.80M | +278.7% |
| Q3 FY2024 | Sep 30, 2024 | $552.47M | – |
| Q2 FY2024 | Jun 30, 2024 | $564.33M | – |
| Q1 FY2024 | Mar 31, 2024 | $579.11M | – |
| Q4 FY2023 | Dec 31, 2023 | $199.30M | – |
See a number that looks wrong?